An Insight on the Possible Association between Inflammatory Bowel Disease and Biologic Therapy with IL-17 Inhibitors in Psoriasis Patients

Psoriasis is a chronic, inflammatory, multisystemic disease which affects approximately 2–3% of the population globally, whose onset is triggered by genetic and environmental factors which activate both dendritic cells and keratinocytes, resulting in the production of proinflammatory cytokines such...

Descripción completa

Detalles Bibliográficos
Autores principales: Orzan, Olguța Anca, Țieranu, Cristian George, Olteanu, Andrei Ovidiu, Dorobanțu, Alexandra Maria, Cojocaru, Anca, Mihai, Mara Mădălina, Popa, Liliana Gabriela, Gheorghiu, Ana Maria, Giurcăneanu, Călin, Ion, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458821/
https://www.ncbi.nlm.nih.gov/pubmed/37631384
http://dx.doi.org/10.3390/pharmaceutics15082171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458821/
https://www.ncbi.nlm.nih.gov/pubmed/37631384
http://dx.doi.org/10.3390/pharmaceutics15082171

Ejemplares similares